Stockscreener 앱 받기
2.9583
0.51%
-0.0117
전일 마감가:
$2.97
열려 있는:
$3.01
하루 거래량:
319.83K
Relative Volume:
0.29
시가총액:
$167.75M
수익:
-
순이익/손실:
$-82.44M
주가수익비율:
-1.5736
EPS:
-1.88
순현금흐름:
$-66.75M
1주 성능:
-6.19%
1개월 성능:
+25.74%
6개월 성능:
+19.64%
1년 성능:
-52.34%
1일 변동 폭
$2.925
$3.08
1주일 범위
$2.925
$3.24
52주 변동 폭
$1.195
$6.75
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
명칭
Black Diamond Therapeutics Inc
전화
617-417-5868
주소
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
BDTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BDTX
Black Diamond Therapeutics Inc
|
2.9501 | 168.88M | 0 | -82.44M | -66.75M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.77 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
566.67 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.78 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.97 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
298.01 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-01 | 재개 | Raymond James | Outperform |
| 2024-07-31 | 개시 | Raymond James | Outperform |
| 2023-07-14 | 개시 | Piper Sandler | Overweight |
| 2023-06-30 | 업그레이드 | Stifel | Hold → Buy |
| 2023-06-28 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-06-27 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2022-03-29 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2022-03-22 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2021-09-30 | 개시 | Stifel | Hold |
| 2021-01-07 | 개시 | Wedbush | Outperform |
| 2020-11-24 | 개시 | Berenberg | Buy |
| 2020-05-04 | 개시 | H.C. Wainwright | Buy |
| 2020-02-24 | 개시 | Canaccord Genuity | Buy |
| 2020-02-24 | 개시 | Cowen | Outperform |
| 2020-02-24 | 개시 | JP Morgan | Overweight |
| 2020-02-24 | 개시 | Jefferies | Buy |
모두보기
Black Diamond Therapeutics Inc 주식(BDTX)의 최신 뉴스
Using portfolio simulators with Black Diamond Therapeutics Inc. includedFree Capital Preserving Trade Plan Templates - Newser
Is Black Diamond Therapeutics Inc. a Top Dividend Stock to Watch in 2025Free Stock Market Strategy Classes - Newser
What institutional investors are buying Black Diamond Therapeutics Inc. stockChart Pattern Guidance To Watch Now - jammulinksnews.com
What are analysts’ price targets for Black Diamond Therapeutics Inc. in the next 12 monthsInvest smarter with expert trading signals - jammulinksnews.com
What are the latest earnings results for Black Diamond Therapeutics Inc.Capitalize on momentum-driven investment opportunities - jammulinksnews.com
What are Black Diamond Therapeutics Inc. company’s key revenue driversMaximize returns with disciplined trading approaches - jammulinksnews.com
Is Black Diamond Therapeutics Inc. a growth stock or a value stockMaximize returns with timely market signals - jammulinksnews.com
Will Black Diamond Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsMarket Trend Watch - Newser
Competitive Positioning of Black Diamond Therapeutics Inc.: Is It Leading or LaggingMinimized Risk Maximum Return - Newser
Is Black Diamond Therapeutics Inc. a good long term investmentUnrivaled growth potential - PrintWeekIndia
Black Diamond Therapeutics Inc. Stock Analysis and ForecastSignificant capital appreciation - PrintWeekIndia
What analysts say about Black Diamond Therapeutics Inc. stockFastest-growing stock picks - PrintWeekIndia
What drives Black Diamond Therapeutics Inc. stock priceTriple-digit growth rates - jammulinksnews.com
Why Black Diamond Therapeutics Inc. stock attracts strong analyst attentionFree Stock Market Forecasting Tools - Newser
Black Diamond Therapeutics, Inc. (BDTX) Rated Outperform as Lead Drug Shows Promise - MSN
why edgewise therapeutics inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser
Black Diamond Therapeutics discloses EGFR inhibitors for cancer - BioWorld MedTech
How Black Diamond Therapeutics Inc. stock performs during market volatilityMarket Beating Strategy - Newser
What makes Black Diamond Therapeutics Inc. stock price move sharplyGroup Only Stock Signals - Newser
Black Diamond Therapeutics Inc (BDTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Black Diamond Therapeutics Inc 주식 (BDTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Versant Venture Capital VI, L. | 10% Owner |
Aug 28 '24 |
Sale |
6.32 |
221,600 |
1,400,556 |
3,726,341 |
0.49%
1.07%
자본화:
|
볼륨(24시간):